UK and Ireland dates
USA and Canada dates
Australia and NZ dates
Rest Of World dates
Featured Testimonials
THOR on Facebook
THOR on Twitter
THOR on LinkedIn
THOR on Instagram
THOR on YouTubeCategories
Essays
Links
Category Archives: THE FUTURE OF PBM/LLLT
James Carroll’s Congress speech on ending opioid use with Photobiomodulation
A hundred million adults in the United States are affected by chronic pain and $600 billion a year is spent on health care, direct health care costs and lost productivity because of pain.
49,000 people died from opioids in 2017, 19,000 of which were from prescribed opioids for pain relief.
We believe that Photobiomodulation therapy can help reduce the prescribing of opioid medication for pain relief and we wish to draw attention to the Congress and health care policymakers, NIH and CMS, about this potentially valuable tool.
Learn more at CongressPBM.com
Watch the Congressional Briefing Highlight Video
Read James Carroll’s Speech to Congress on citizenoversight.blogspot.com
Posted in Industry, James in Action, THE FUTURE OF PBM/LLLT, Video of the Week
on James Carroll’s Congress speech on ending opioid use with Photobiomodulation
Building NovoTHOR: It starts with Quality components
Making a NovoTHOR starts with designing and manufacturing quality components. Testing occurs throughout the build process to ensure the NovoTHOR meets strict requirements for light distribution and dose for maximum effectiveness.
More NovoTHOR Testimonials | NovoTHOR Treatment Locations
View current photobiomodulation therapy training dates in your location.
Posted in THE FUTURE OF PBM/LLLT, Video of the Week
on Building NovoTHOR: It starts with Quality components
Building NovoTHOR: Made in the USA
We make NovoTHOR in the USA, working with experts in LED manufacturing who have a passion for excellence. They implement testing and quality systems to ensure every aspect is built to our high standards.
More NovoTHOR Testimonials | NovoTHOR Treatment Locations
View current photobiomodulation therapy training dates in your location.
Posted in Industry, THE FUTURE OF PBM/LLLT, Video of the Week
on Building NovoTHOR: Made in the USA
THOR laser in UK National Health Service (NHS) clinical trial for treatment of Oral Mucositis
Laser therapy to ease cancer treatment side effects | ITV News
MPH LiTFORM ITV news release Sept 2018
Read more on Photobiomodulation Therapy for reducing severity and duration of oral mucositis.
Posted in Industry, THE FUTURE OF PBM/LLLT, Video of the Week
on THOR laser in UK National Health Service (NHS) clinical trial for treatment of Oral Mucositis
Shining a Light on PBM & The Health Care Innovation Ecosystem
By Ms. Hannah M Clark, Global NetGeneration of Youth Cyberjournalist, with support from Dr. Ronnie Lowenstein, Executive Director Global NetGeneration of Youth
Recently, I was honored to be invited by Dr. Robert Boege, Executive Director of ASTRA to join ASTRA’s Futurist Dr. Ronnie Lowenstein, and serve as a NetGeneration of Youth Cyberjournalist covering a Congressional Briefing held in the Rayburn House Office Building on October 11, 2018 entitled, “Ending Opioid Use: A New Hope”. The event was co-sponsored by ASTRA, The World Association for Laser Therapy, NetGeneration of Youth, The Optical Society of America, and thirteen other science and medical organizations. What an opportunity to learn about PBM, “photobiomodulation,” an innovative medical technology, as well as, to be exposed to the organizational stakeholders who advocate for support of America’s ‘science and technology innovation ecosystem.’
What is PBM and What does it Promise?
When I first heard the term photobiomodulation (PBM) I was confused—initially the word sounded like … Continue reading
Posted in Industry, THE FUTURE OF PBM/LLLT
on Shining a Light on PBM & The Health Care Innovation Ecosystem
New Technologies, Treatments Can End Opioid Use
Those suffering from America’s opioid crisis recently received two major messages of hope.
On Oct. 24, President Donald Trump signed the Opioid Crisis Response Act (OCRA) into law. Dozens of bills designed to address the diverse aspects of the opioid crisis were consolidated into one strategic and integrated approach.
OCRA received overwhelming bi-partisan support in both Chambers.
HR6, which is now Public Law 115-2716, broke new ground in being the first legislation to mandate aggressive development and adoption of alternative pain treatments that include “innovative medical technologies for pain management.”
On Oct. 11, Congress held its first ever briefing on ending opioid use through “innovative medical technologies for pain management.”
Photobiomodulation (PBM) was the featured technology.
Read the full news story on newsmax.com
Posted in Industry, THE FUTURE OF PBM/LLLT
on New Technologies, Treatments Can End Opioid Use
THOR CEO leads official US Congressional Briefing on Photobiomodulation (PBM)
Washington DC, 11th October, 2018. James Carroll (CEO, THOR Photomedicine), Prof. Praveen Arany (University at Buffalo, NY), Annette Quinn RN (Program Manager, Radiation Oncology, University of Pittsburgh (UPMC) Cancer Center) introduced Photobiomodulation (PBM) to a large gathering of senior policy officials at the Rayburn House Office Building.
James Carroll presented evidence to Congress on the effectiveness of PBM for treating pain and where it can be used in place of opioids. Prof. Praveen Arany explained how and why it works, and Annette Quinn RN gave her first hand experience in treating over 854 patients with Oral Mucositis.
The briefing was a historic step for PBM, moving the conversation forward as members of congress were shown stories by members of the public on how PBM had impacted them and enabled them to live a life free from opioids.
The panel outlined the needs for PBM adoption as
- Research grants to fund further basic science experiments, therapeutic dose, and large multicenter … Continue reading
Posted in Industry, THE FUTURE OF PBM/LLLT
on THOR CEO leads official US Congressional Briefing on Photobiomodulation (PBM)